In This Store
Factory Location: Suzhou
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: L/L
For containment and blinding of comparator products in double-blinding clinical trial studies, look to DBcaps® capsules.
DBcaps® capsules were developed with a tamper-evident design to specifically address the clinical trial challenges of testing without bias. DBcaps® capsules are available in 8 sizes and both gelatin and HPMC.
The wider diameter of opaque DBcaps® capsules allows containment and blinding of large-diameter or uniquely-shaped tablets or other comparator products, while their shorter length makes them easier to swallow.
Innovative Design Helps Improve Patient Compliance
DBcaps® Size C Capsule
Standard Size 0 Capsule
DBcaps® capsules are shipped in fiber-free, corrugated polypropylene containers* and will arrive in a sturdy, recyclable box that is anti-static incorporated.
This leading-edge pharmaceutical practice allows packaging (pallets or box) entry into cGMP environments. Polypropylene is insoluble in water, can be wiped with alcohol, and replaces the need for transferring from fiber to fiber-free containers. It reduces labor costs associated with manual handling, simplifies restocking and eliminates relabeling activities. A locking bottom with a protective pad ensures secure containment as soon as it arrives.
DBcaps® capsules are also available in a convenient CapsuleCaddy™ Container *, perfect for clinical trial batches and R&D projects.
*Contact your Lonza representative for availability in your region.
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194